10.3390/ijms232214251 [DOI] [PMC free article] [PubMed] [Google Scholar] Emmanuelle B., Larissa L., Marielle B., Houssaini A., Beaulieu D., Marcos E., et al
the parallel fosgonimeton LIFT-AD failure and the pro-proliferative c-Met concern and why hype is not evidence, and sleep, exercise and fuel come first, not a dye or a peptide
The recurring methodological feature across these subliteratures is small effect sizes, variable replication, and operational endpoints (EEG patterns, behavioral scores, plasma hormone levels) that cannot, on their own, identify a target
As a complementary approach, rational prodrug designs and receptor-targeted conjugates should be explored to restrict activation to cells that overexpress disease-associated markers in the endometriotic microenvironment
A.FerreiraS